EDGAR Filing Documents for 0001015820-17-000046

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001015820-17-000046

Filing Date

2017-11-07

Accepted

2017-11-07 19:24:43

Documents

Period of Report

2017-10-26

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	wf-form4_151010066967630.html	4
1	FORM 4	wf-form4_151010066967630.xml	4	4245
	Complete submission text file	0001015820-17-000046.txt		6040

Mailing Address HULSTERWEG 82 PL VENLO P7 5912

Business Address HULSTERWEG 82 PL VENLO P7 5912 31-77-35566-00

QIAGEN NV (Reporting) CIK: 0001015820 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37369 | Film No.: 171184772
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3430 E. GLOBAL LOOP TUCSON AZ 85706

Business Address 3430 E. GLOBAL LOOP TUCSON AZ 85706 877-289-2615

HTG MOLECULAR DIAGNOSTICS, INC (Issuer) CIK: 0001169987 (see all company filings)

IRS No.: 860912294 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments